Pharma giant Merck is stopping a key Alzheimer’s trial because there’s ‘virtually no chance of finding a positive clinical effect’ February 15, 2017medicinehistoryscoper http://www.businessinsider.com/merck-to-halt-study-of-mild-to-moderate-alzheimers-drug-2017-2